APA (7th ed.) Citation

Hahnen, E. T., Hauke, J., Gelmon, K., Marmé, F., Ernst, C., Martin, M., . . . Loibl, S. (2025). BRCA1/2 and other predisposition genes in high-risk hormone receptor+/human epidermal growth factor receptor 2- breast cancer treated with endocrine therapy with or without palbociclib: A secondary PENELOPE-B study analysis : original reports : biomarkers. JCO precision oncology, 9, . https://doi.org/10.1200/PO-24-00742

Chicago Style (17th ed.) Citation

Hahnen, Eric Thomas, et al. "BRCA1/2 and Other Predisposition Genes in High-risk Hormone Receptor+/human Epidermal Growth Factor Receptor 2- Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis : Original Reports : Biomarkers." JCO Precision Oncology 9 (2025). https://doi.org/10.1200/PO-24-00742.

MLA (9th ed.) Citation

Hahnen, Eric Thomas, et al. "BRCA1/2 and Other Predisposition Genes in High-risk Hormone Receptor+/human Epidermal Growth Factor Receptor 2- Breast Cancer Treated with Endocrine Therapy with or Without Palbociclib: A Secondary PENELOPE-B Study Analysis : Original Reports : Biomarkers." JCO Precision Oncology, 9, 2025, https://doi.org/10.1200/PO-24-00742.